Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from TGA

Confusing for doctors, inequitable for patients: why Australia’s medicinal cannabis system needs urgent reform

In 2024 alone, Australia’s medicines regulator, the Therapeutic Goods Administration (TGA), authorised at least 979,000 prescription applications for medicinal cannabis through its specialised access pathways.

The Conversation

Can I trust my sunscreen? Choice test results have created uncertainty over SPF claims and lab testing process

With Australia having one of the highest rates of skin cancer in the world, the consumer advocate group’s report left many worried and wondering about the brands they use

The Guardian - AU

The danger of too much vitamin B6 – and three symptoms to look out for

The Australian regulator admits it may have underestimated the extent of the side effects from vitamin B6 supplements

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Does Australia really take too long to approve medicines, as the US says?

Australia’s drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.

The Conversation

What Gen Z Needs To Know About Crackdowns On Medical Cannabis Prescriptions

Australia's health-practitioner watchdog has released guidance for doctors prescribing medicinal cannabis, noting current data has raised "red flags".

Pedestrian.tv

Australia’s Top Sunscreen Brands May Need To Change Their Formulas Following A Review

Sunscreen manufacturers in the country may soon need to reformulate their products to add safeguards regarding two active ingredients.

Pedestrian.tv

Too much vitamin B6 can be toxic. 3 symptoms to watch out for

Side effects from taking too much vitamin B6 – including nerve damage – may be more widespread than we think, Australia’s medicines regulator says.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Australians with ADHD could face drug shortages for rest of year, TGA says

People with neurodevelopmental disorder advised to contact their doctor while experts say alternative medications available

The Guardian - AU

Ban on gay and bisexual men donating blood and plasma in Australia to be scrapped

Lifeblood heralds ‘world-leading plasma pathway’ amid change to HIV-era restrictions

The Guardian - AU

Australia’s Sunscreen Saga Continues As CHOICE Doubles Down On Test Results

CHOICE has doubled down on its recent sunscreen testing, which found only four out of 20 popular sunscreens met their label claim of SPF50.

Pedestrian.tv

Low pharmacy vaping uptake fuels black market fears

Only about 40,000 vapes have been sold via the federal government's pharmacy model, which critics say shows black market sales are still thriving.

AAP

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

The Conversation

Only 4 Of 20 Popular Aussie Sunscreens Are Meeting The SPF Claims On Their Label, According To CHOICE

Australia's peak consumer advocacy group put 20 sunscreens to the test, finding most didn’t actually hit the SPF50 mark.

Pedestrian.tv

Four in five sunscreens fail SPF test: consumer group

The Cancer Council is disputing the findings of tests on popular sunscreens in Australia that show 16 out of 20 don't match the SPF 50+ ratings on their tubes.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Several leading Australian sunscreens don’t provide the protection they say, Choice finds

Consumer group tested 20 popular SPF 50 and 50+ brands and found 16 didn’t meet the claims on the bottles

AAP

Tech giant sued over sleep aid foam inhalation 'risk'

Recalled Philips sleep apnoea devices posed dangers for users inhaling or ingesting small pieces of foam due to degradation, a government lawsuit claims.

The Conversation

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

Fortune

'Hated' Ethereum due for a comeback says crypto icon Arthur Hayes

The BitMEX founder thinks a spending spree by the U.S. Treasury will help lift the price of Bitcoin.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

More people are trying medicinal cannabis for chronic pain. But does it work?

More Australians than ever are being prescribed medicinal cannabis.

The Conversation

Trump has Australia’s generic medicines in his sights. And no-one’s talking about it

While Australia was busy defending the Pharmaceutical Benefits Scheme against threats from the United States in recent weeks, another issue related to the supply and trade of medicines was flying under the radar.

The Guardian - AU

NAD boosters: Kendall Jenner and Hailey Bieber are into them, but do they actually stop ageing?

Despite social media hype, there is little evidence that the therapies, marketed as pills, shots and IV infusions, have any effects on ageing

Inverse

55 Years Ago, A Wildly Influential Disaster Thriller Invented A New Genre — And Changed Hollywood Forever

More than half a century after its release, Hollywood continues to pay its dues to 'Airport,' the grandaddy of the modern disaster movie.

The Guardian - AU

Botched Botox jabs can be dangerous. Some Australians don’t even realise what they’re receiving

The healthcare complaints watchdog says at least two unnamed Sydney practitioners, allegedly posing as accredited medical professionals, are under investigation

The Guardian - AU

Weight loss drug Wegovy approved to treat heart disease in overweight and obese Australian patients

TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided

The Conversation

Menopause hormone patches are in short supply. What are they? And how do they compare with other therapies?

The federal government yesterday released its response to the Senate inquiry into issues related to menopause. The inquiry recommended the government examine options to make menopause hormone therapy (MHT, or sometimes called hormone replacement therapy) more affordable and accessible, and address drug shortages.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.